1419711-40-2

Upstream product

• 1419711-20-8 prop-2-en-1-yl 2-(acetylamino)-4,6-O-benzylidene-2-deoxy-3-O-{2,3-di-O-benzoyl-4-O-[tert-butyl(dimethyl)silyl]-β-D-glucopyranosyl}-α-D-glucopyranoside 
• 1419711-15-1 prop-2-en-1-yl 2-(acetylamino)-4,6-O-benzylidene-2-deoxy-3-O-{2,3-di-O-benzoyl-4-O-[tert-butyl(dimethyl)silyl]-6-O-(4-methoxybenzyl)-β-D-glucopyranosyl}-α-D-glucopyranoside 
• 74984-84-2 prop-2-en-1-yl 2-(acetylamino)-4,6-O-benzylidene-2-deoxy-α-D-glucopyranoside 
• 74-88-4 methyl iodide 

Downstream Products

• 1419711-45-7 prop-2-en-1-yl 2-(acetylamino)-4,6-O-benzylidene-2-deoxy-3-O-(2,3-di-O-benzoyl-6-methyl-β-D-(¹³C₆)glucopyranosyl)-α-D-glucopyranoside 

Relevant academic research and scientific papers

Synthesis of 13C-labeled and functionalized Hyaluronan derivatives for biophysical studies and surface modifications

A convergent synthesis of a tetrasaccharide partial sequence of 13C-labeled Hyaluronan is presented. This tetrasaccharide can be used for biophysical studies as well as for surface modifications. Furthermore, tetrasaccharide 7 can be employed for the synthesis of additionally labeled higher oligomers of Hyaluronan on the basis of the presented methodology.